Additional European Equity News
AstraZeneca (AZN LN) - AstraZeneca’s Imfinzi has been recommended for approval in the EU for bladder cancer, with the company noting it was well tolerated and no new safety signals were observed.
DCC (DCC LN) - Launch of GBP 100mln share buyback. (Newswires)
Sanofi (SAN FP) - Co. launches vaccine factory in Vietnam. (Newswires)
Serco (SRP LN) - Completed acquisition of MTS. Outlook 2025: Revenue of around GBP 4.8bln. Adverse translation impact of currency movements for 2025 exp. to be around GBP 90mln for rev. and GBP 7mln for underlying op. profit. (Newswires)
Whitbread (WTB LN) - Hodgson appointed as Chair of Co. (Newswires)
FLSmidth (FLS DC) upgraded to Buy from Neutral at Goldman Sachs
27 May 2025 - 07:05- EquitiesEU Research- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts